Substituted isoindoles and their use thereof

Details Substituted isoindoles and their use thereof Substituted isoindoles and their use thereof

2007-03-13

2007-03-13

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S323000, C546S194000, C546S201000

Reexamination Certificate

active

10485412

ABSTRACT:
The invention relates to coagulation of the blood. Disclosed are novel compounds of formula (I),a method for the production of these compounds, pharmaceutical compositions containing them, and methods of using them for the prevention and/or treatment of various diseases.

REFERENCES:
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 2003/0045552 (2003-03-01), Robarge et al.
patent: 9900121 (1999-01-01), None
patent: 9906371 (1999-02-01), None
patent: 9937304 (1999-07-01), None
patent: 0177075 (2001-10-01), None
patent: 0234711 (2002-05-01), None
Database Chemcats ′Online!, Chemical Abstract Service, Columbus, Ohio, US; retrieved from STN, XP002215164, order No. F0161-0413 & “Interchim Intermediates,” Jul. 9, 2002, Interchim, 213 Avenue Kentucky, BP 1140, Montlucon, Cedex 03103, France.
Japtap, et al., “Preparation of nucleosides and isoindolinone derivatives as anit-inflamatory agents,” STN International, HCAPLUS, Documen No. 135:304105 (2005).
Database Chemcats ′Online!, Chemical Abstracts Service, Columbus, Ohio, US; retrieved from STN, XP002215164, order No. F0161-0413 & “Interchim Intermediates”, Jul. 9, 2002, Interchim, 213 Avenue Kennedy, BP 1140, Montlucon, Cedex 03103, France.
Rohrer, et al., “Iron Environment in Ferritin with Large Amounts of Phosphate, fromAzotobacter vinelandiiand Horse Spleen, Analyzed Using Extended X-ray Absorption Fine Structure (EXAFS)”, Biochemistry, 29: 259-264 (1990).
Pschyrembel, Klinisches Wörterbuch, 257thEdition 1994, Walter de Gruyter Verlag, pp. 199-200.
Pschyrembel, Klinisches Wörterbuch, 257thEdition 1994, Walter de Gruyter Verlag, pp. 292-293.
Pschyrembel, Klinisches Wörterbuch, 257thEdition 1994, Walter de Gruyter Verlag, pp. 160-161.
Hauptmann, et al., “Synthetic Inhibitors of Thrombin and Factor Xa: From Bench to Bedside”, Thrombosis Res., 93: 203-241 (1999).
Al-Obeidi, et al., “Factor Xa inhibitors by classical and combinatorial chemistry”, DDT, 3(5): 223-231 (1998).
Al-Obeidi, et al., “Factor Xa inhibitors”, Exp. Opin. Ther. Patents, 9(7): 931-953 (1999).
Kaiser, B., “Thrombin and factor Xa inhibitors”, Drugs of the Future, 23(4): 423-436 (1998).
Uzan, A., “Antithrombotic agents”, Emerging Drugs, 3: 189-208 (1998).
Zhu, et al., “Recent advances in inhibitors of factor Xa in the prothrombinase complex”, Curr. Opin. Card. Pulm. Ren. Inv. Drugs, 1(1): 63-87 (1999).
Berry, et al., “Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time”, Br. J. Pharmacol., 113: 1209-1214 (1994).
Meng, et al., “Effect of Acetylsalicylic Acid on Experimentally Induced Arterial Thrombosis in Rats”, Naunyn-Schmiedeberg's Arch. Pharmacol., 301: 115-119 (1977).

Affiliated with

Also associated with

Rating

Substituted isoindoles and their use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted isoindoles and their use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted isoindoles and their use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3791891